Ascendis Pharma A/S is a biopharmaceutical company that focuses on developing innovative drug therapies for unmet medical needs. The company employs its proprietary TransCon technology platform to cre... Ascendis Pharma A/S is a biopharmaceutical company that focuses on developing innovative drug therapies for unmet medical needs. The company employs its proprietary TransCon technology platform to create therapeutic products that improve efficacy and therapeutic outcomes. Ascendis Pharma primarily targets endocrinology, aiming to treat conditions such as growth hormone deficiencies and hypoparathyroidism. The company's commitment to integrating advanced biotechnology through TransCon allows for sustained release and limited side effects, offering efficient and effective treatment options. Headquartered in Denmark, Ascendis Pharma plays a significant role in the biotech sector, driving innovation with a strong emphasis on developmental pipeline and collaborations designed to address complex diseases. With its growing presence and dedicated R&D initiatives, Ascendis continues to make critical contributions to the healthcare industry by delivering promising new therapies for rare conditions.Show lessShow more

Disclosures ESG Data Financial Data

GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

Data not available

No Climate Targets data disclosed by Ascendis Pharma

We reviewed Ascendis Pharma's website and available disclosure materials for the 2023 reporting period and did not identify any reported Climate Targets data.

If you would like us to review newly published materials or reassess the most recent disclosures, you can submit a data update request.

Would you like us to review Ascendis Pharma's data?

Start your 30-day free trial to request a data review for Ascendis Pharma.

Start Free Trial

Legal Center Contact Us